Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis
Authors:
- 23 August 2014
- journal article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 92 (12) , 1293-1304
Abstract
We studied HLA class II molecules on blood monocyte subsets, blood dendritic cells, sputum macrophages, and monocyte-derived macrophages at the protein (flow cytometry) and mRNA level (RT-PCR) in adult patients with cystic fibrosis (CF) and healthy control subjects as putative contributors to the CF phenotype. In healthy donors, we found a high average HLA-DQ expression of 4.35 mean specific fluorescence intensity units (ΔMnI) on classical blood monocytes. In F508del homozygous CF patients, the average ΔMnI was low (1.80). Patients were divided into two groups, in which 14 of these patients had HLA-DQ expression above 2 ΔMnI (average 3.25 ΔMnI, CF-DQgroup1) and 36 below (average 1.24 ΔMnI, CF-DQgroup2). Also, the CD16-positive monocyte subset and blood dendritic cells showed much lower levels of HLA-DQ for the CF-DQgroup2 patients compared with healthy controls. In macrophages from sputum and derived from monocytes, in vitro HLA-DQ expression was dramatically decreased to background levels in CF-DQgroup2. MHC class II transcripts were reduced in CF with a sevenfold decrease in HLA-DQβ1 for CF-DQgroup2 patients. Higher levels of the inflammation marker CRP were associated with low HLA-DQ protein expression, and in vitro treatment with the inflammatory molecule lipopolysaccharide reduced HLA-DQ expression. Interferon γ (IFNγ) could overcome this effect in healthy donor cells while, in CF, the IFNγ-induced activation was impaired. Our data demonstrate a pronounced reduction of HLA-DQ expression in CF, which is associated with inflammation and a reduced response to IFNγ. • CF patients show a reduced expression of MHCII molecules in monocytes and macrophages. • HLA-DQ and HLA-DR transcript levels are also reduced in CF patients. • CF patient C-reactive protein levels correlate with low HLA-DQ expression. • Reduced expression of MHC class II molecules appears to be linked to inflammation. • CF patients exhibit an impaired response to IFNgamma.Keywords
This publication has 28 references indexed in Scilit:
- Translocated LPS Might Cause Endotoxin Tolerance in Circulating Monocytes of Cystic Fibrosis PatientsPLOS ONE, 2011
- Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammationCritical Care, 2010
- A novel approach to analyze gene expression data demonstrates that the ΔF508 mutation in CFTR downregulates the antigen presentation pathwayAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Ultrafine carbon particles down-regulate CYP1B1 expression in human monocytesParticle and Fibre Toxicology, 2009
- HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistanceBMC Infectious Diseases, 2009
- The CD14+ CD16+ blood monocytes: their role in infection and inflammationJournal of Leukocyte Biology, 2006
- A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilmsProceedings of the National Academy of Sciences, 2006
- The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosisInternational Immunology, 2006
- Monocyte deactivation-rationale for a new therapeutic strategy in sepsisIntensive Care Medicine, 1996
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993